Q: What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.
 The Molecule can be represented with the SMILES CC(Cc1ccc(O)cc1)NCC(O)c1cc(O)cc(O)c1.
Answer: Approved
{#Question|Q!}: {quest#}
{#Constraint:|Description:|!} The {#Molecule|Compound|Chemical!} {#has the|can be represented with the!} {SMILES__description} {SMILES#}.
{#Answer|Result|Answer!}: {answ#}
CC(Cc1ccc(O)cc1)NCC(O)c1cc(O)cc(O)c1
CC(Cc1ccc(O)cc1)NCC(O)c1cc(O)cc(O)c1
5-[1-hydroxy-2-[[1-(4-hydroxyphenyl)propan-2-yl]amino]ethyl]benzene-1,3-diol
What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.